• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Susceptibility and bactericidal activity studies of four beta-lactamase-producing enterococci.四种产β-内酰胺酶肠球菌的药敏及杀菌活性研究
Antimicrob Agents Chemother. 1989 Feb;33(2):251-3. doi: 10.1128/AAC.33.2.251.
2
Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis.产β-内酰胺酶、耐氨基糖苷类粪肠球菌分离株的抗菌药敏性及分子流行病学
Antimicrob Agents Chemother. 1991 Jun;35(6):1075-80. doi: 10.1128/AAC.35.6.1075.
3
Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci.
Diagn Microbiol Infect Dis. 1991 Nov-Dec;14(6):495-9. doi: 10.1016/0732-8893(91)90005-z.
4
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.头孢比普对粪肠球菌的时间杀菌及协同作用研究，包括产β-内酰胺酶和耐万古霉素菌株。
Antimicrob Agents Chemother. 2007 Jun;51(6):2043-7. doi: 10.1128/AAC.00131-07. Epub 2007 Apr 16.
5
Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.达托霉素（LY 146032）与四种对照抗生素单独及联合使用时，对庆大霉素敏感和高水平庆大霉素耐药肠球菌的体外抑制和杀菌活性比较。
Chemotherapy. 1993 Sep-Oct;39(5):302-9. doi: 10.1159/000239141.
6
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.氨苄西林-舒巴坦与万古霉素治疗由产β-内酰胺酶、对庆大霉素高度耐药的粪肠球菌分离株引起的实验性心内膜炎的比较。
Antimicrob Agents Chemother. 1993 Jul;37(7):1447-51. doi: 10.1128/AAC.37.7.1447.
7
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.奥利万星及对照药物对金黄色葡萄球菌、粪肠球菌和屎肠球菌的时间杀菌动力学
J Antimicrob Chemother. 2009 Jun;63(6):1191-9. doi: 10.1093/jac/dkp126. Epub 2009 Apr 15.
8
Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.对由产β-内酰胺酶、耐氨基糖苷类肠球菌引起的实验性心内膜炎的化学预防效果与血清抑制活性延长有关。
Antimicrob Agents Chemother. 1990 Jun;34(6):1068-74. doi: 10.1128/AAC.34.6.1068.
9
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.评价替加环素对金黄色葡萄球菌和对万古霉素、达托霉素或利奈唑胺敏感性降低的肠球菌的抗菌活性。
J Antimicrob Chemother. 2016 Jan;71(1):152-5. doi: 10.1093/jac/dkv302. Epub 2015 Oct 16.
10
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.曲伐沙星与其他抗生素联合对肠球菌的体外活性
Diagn Microbiol Infect Dis. 1997 Dec;29(4):233-9. doi: 10.1016/s0732-8893(97)00161-2.

引用本文的文献

1
Microscopic Analysis of Bacterial Inoculum Effect Using Micropatterned Biochip.使用微图案生物芯片对细菌接种物效应进行显微镜分析。
Antibiotics (Basel). 2021 Mar 13;10(3):300. doi: 10.3390/antibiotics10030300.
2
Genetic diversity among Enterococcus faecalis.屎肠球菌的遗传多样性。
PLoS One. 2007 Jul 4;2(7):e582. doi: 10.1371/journal.pone.0000582.
3
Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.所选青霉素、β-内酰胺酶抑制剂组合及糖肽类药物对粪肠球菌的活性及杀菌时间研究
Antimicrob Agents Chemother. 1998 Apr;42(4):857-61. doi: 10.1128/AAC.42.4.857.
4
DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level.用于将肠球菌鉴定到种水平的DNA杂交和轮廓夹钳均匀电场电泳
J Clin Microbiol. 1995 Jan;33(1):141-5. doi: 10.1128/jcm.33.1.141-145.1995.
5
Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.舒巴坦在需氧/厌氧混合感染体外模型中的疗效。
Infection. 1990 Mar-Apr;18(2):117-21. doi: 10.1007/BF01641431.
6
Pathogenicity of the enterococcus in surgical infections.肠球菌在外科感染中的致病性。
Ann Surg. 1990 Aug;212(2):155-9. doi: 10.1097/00000658-199008000-00007.
7
In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.细胞壁活性抗生素杀菌活性的体外反应并不支持肠球菌对这些抗生素天然耐药的普遍观点。
Antimicrob Agents Chemother. 1990 Aug;34(8):1518-22. doi: 10.1128/AAC.34.8.1518.
8
Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.替考拉宁两种给药方案对由产β-内酰胺酶且对庆大霉素高度耐药的粪肠球菌菌株引起的实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 1990 May;34(5):827-30. doi: 10.1128/AAC.34.5.827.
9
Isolation of three strains of beta-lactamase-producing Enterococcus faecalis in Argentina.在阿根廷分离出三株产β-内酰胺酶的粪肠球菌。
Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):402-5. doi: 10.1007/BF01979469.
10
Ampicillin-resistant enterococci.耐氨苄西林肠球菌
J Clin Microbiol. 1990 Apr;28(4):829. doi: 10.1128/jcm.28.4.829-.1990.

本文引用的文献

1
Method of reliable determination of minimal lethal antibiotic concentrations.可靠测定最低致死抗生素浓度的方法。
Antimicrob Agents Chemother. 1980 Nov;18(5):699-708. doi: 10.1128/AAC.18.5.699.
2
Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.可转移的β-内酰胺酶。粪肠球菌体外青霉素耐药的一种新机制。
J Clin Invest. 1983 Sep;72(3):1168-71. doi: 10.1172/JCI111042.
3
Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci.肠球菌临床分离株中对氨基糖苷类高水平耐药的发生率。
Antimicrob Agents Chemother (Bethesda). 1970;10:335-40.
4
Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.万古霉素-庆大霉素及万古霉素-链霉素对肠球菌的协同作用。
Antimicrob Agents Chemother. 1973 Aug;4(2):120-4. doi: 10.1128/AAC.4.2.120.
5
In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.环丙沙星对从感染性心内膜炎患者分离出的肠球菌的体外和体内活性。
Antimicrob Agents Chemother. 1987 Mar;31(3):430-3. doi: 10.1128/AAC.31.3.430.
6
Serious infection due to beta-lactamase-producing Streptococcus faecalis with high-level resistance to gentamicin.由产β-内酰胺酶且对庆大霉素高度耐药的粪肠球菌引起的严重感染。
J Infect Dis. 1988 Nov;158(5):1144-5. doi: 10.1093/infdis/158.5.1144.
7
Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous.来自不同地理区域的肠球菌庆大霉素耐药质粒具有异质性。
J Infect Dis. 1988 Jul;158(1):212-6. doi: 10.1093/infdis/158.1.212.
8
Enterococcal superinfection in patients treated with ciprofloxacin.接受环丙沙星治疗的患者发生肠球菌二重感染。
J Antimicrob Chemother. 1988 Jan;21(1):113-5. doi: 10.1093/jac/21.1.113.
9
Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.两种产青霉素酶粪肠球菌（肠球菌）菌株的特性鉴定与比较。
Antimicrob Agents Chemother. 1988 Jan;32(1):122-4. doi: 10.1128/AAC.32.1.122.
10
beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.耐氨基糖苷类粪肠球菌所致实验性心内膜炎中β-内酰胺酶的产生
J Infect Dis. 1987 Jun;155(6):1226-32. doi: 10.1093/infdis/155.6.1226.

四种产β-内酰胺酶肠球菌的药敏及杀菌活性研究

Susceptibility and bactericidal activity studies of four beta-lactamase-producing enterococci.

作者信息

Patterson J E, Zervos M J

机构信息

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.

出版信息

Antimicrob Agents Chemother. 1989 Feb;33(2):251-3. doi: 10.1128/AAC.33.2.251.

DOI:10.1128/AAC.33.2.251
PMID:2497706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC171469/
Abstract

beta-Lactamase-producing (Bla+) enterococci are rare but have been reported from several areas. We report another Bla+ enterococcus with high-level gentamicin resistance. Susceptibility and bactericidal activity studies of four Bla+ enterococci against potential alternative antibiotics, including ampicillin-sulbactam, daptomycin, teicoplanin, and vancomycin, are presented.

摘要

产β-内酰胺酶（Bla+）的肠球菌较为罕见，但已有多个地区报道过。我们报告了另一株对庆大霉素具有高水平耐药性的Bla+肠球菌。本文介绍了4株Bla+肠球菌对包括氨苄西林-舒巴坦、达托霉素、替考拉宁和万古霉素在内的潜在替代抗生素的敏感性和杀菌活性研究。